文献速递肿瘤 PET/CT

18F-DCFPyL PET/CT 在 60 分钟和 120 分钟检测前列腺癌:检出率、图像质量、放射性动力学及生物分布

18F-DCFPyL PET/CT in the Detection of Prostate Cancer at 60 and 120 Minutes: Detection Rate, Image Quality, Activity Kinetics, and Biodistribution.
PubMed 文献 · J Nucl Med · 2017-04-27

该研究在 66 例经组织病理学证实的前列腺癌患者中,比较注射 18F-DCFPyL 后 60 分钟与 120 分钟 PET/CT 的病灶检出、图像质量和示踪剂动力学。结果显示 120 分钟时 203 个前列腺癌特征性病灶的摄取显著高于 60 分钟(中位数 10.78 vs 12.86,P < 0.001),38.5% 患者检出更多病灶,9.2% 患者 TNM 分期发生改变,信噪比在 120 分钟也显著更优(11.93 vs 11.15,P < 0.001)。

要点

  • 注射 18F-DCFPyL 后 120 分钟较 60 分钟检出更多前列腺癌特征性病灶,203 个病灶摄取中位数 10.78 vs 12.86(P < 0.001)。
  • 38.5% 的患者在 120 分钟图像上显示更多病灶,9.2% 的患者 TNM 分期发生改变。
  • 120 分钟图像平均信噪比为 11.93,显著优于 60 分钟的 11.15(P < 0.001)。

核心结论

  • 注射 18F-DCFPyL 后 120 分钟 PET/CT 图像对前列腺癌特征性病灶的检出率高于 60 分钟图像。
  • 需要进一步研究以阐明 18F-DCFPyL 的最佳成像时间点。

研究设计与样本

  • 连续纳入 66 例经组织病理学证实的前列腺癌患者,在注射 18F-DCFPyL 后 60 分钟和 120 分钟分别行 PET/CT 成像。
  • 采用视觉分析按解剖部位(前列腺、精囊、局部淋巴结、远处淋巴结、骨及其他)报告两个时间点的阳性病灶,并评估图像质量及对前列腺癌病灶和正常组织示踪剂活性进行半定量分析。

主要发现

  • 203 个前列腺癌特征性病灶在注射后 60 至 120 分钟之间 18F-DCFPyL 摄取显著增加(中位数 10.78 vs 12.86,P < 0.001,Wilcoxon 符号秩检验)。
  • 视觉分析显示,38.5% 的患者在 120 分钟图像上比 60 分钟图像显示更多病灶,9.2% 的患者 TNM 分期发生改变。
  • 60 分钟图像上可见的所有病灶在 120 分钟图像上均可见。
  • 120 分钟图像的平均信噪比为 11.93,显著优于 60 分钟的 11.15(P < 0.001,配对 t 检验)。

关键数值与推荐

  • 前列腺癌特征性病灶 18F-DCFPyL 摄取中位数:60 分钟为 10.78,120 分钟为 12.86(P < 0.001)。
  • 平均信噪比:120 分钟为 11.93,60 分钟为 11.15(P < 0.001)。
  • 视觉分析显示 38.5% 的患者在 120 分钟检出更多病灶,9.2% 的患者 TNM 分期改变。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要进一步研究以阐明 18F-DCFPyL 的最佳成像时间点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

There is increasing interest in PET/CT with prostate-specific membrane antigen (PSMA) tracers for imaging of prostate cancer because of the higher detection rates of prostate cancer lesions than with PET/CT with choline. For 68Ga-PSMA-11 tracers, late imaging at 180 min after injection instead of imaging at 45-60 min after injection improves the detection of prostate cancer lesions. For 18F-DCFPyL, improved detection rates have recently been reported in a small pilot study. In this study, we report the effects of PET/CT imaging at 120 min after injection of 18F-DCFPyL in comparison to images acquired at 60 min after injection in a larger clinical cohort of 66 consecutive patients with histopathologically proven prostate cancer. Methods: Images were acquired 60 and 120 min after injection of 18F-DCFPyL. We report the positive lesions specified for anatomic locations (prostate, seminal vesicles, local lymph nodes, distant lymph nodes, bone, and others) at both time points by visual analysis, the image quality at both time points, and a semiquantitative analysis of the tracer activity in both prostate cancer lesions as well as normal tissues at both time points. Results: Our data showed a significantly increasing uptake of 18F-DCFPyL between 60 and 120 min after injection in 203 lesions characteristic for prostate cancer (median, 10.78 vs. 12.86, P < 0.001, Wilcoxon signed-rank test). By visual analysis, 38.5% of all patients showed more lesions using images at 120 min after injection than using images at 60 min after injection, and in 9.2% a change in TNM staging was found. All lesions seen on images 60 min after injection were also visible on images 120 min after injection. A significantly better mean signal-to-noise ratio of 11.93 was found for images acquired 120 min after injection (P < 0.001, paired t test; signal-to-noise ratio at 60 min after injection, 11.15). Conclusion:18F-DCFPyL PET/CT images at 120 min after injection yield a higher detection rate of prostate cancer characteristic lesions than images at 60 min after injection. Further studies are needed to elucidate the best imaging time point for 18F-DCFPyL.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Wondergem M, van der Zant FM, Knol RJJ, et al. 18F-DCFPyL PET/CT in the Detection of Prostate Cancer at 60 and 120 Minutes: Detection Rate, Image Quality, Activity Kinetics, and Biodistribution. J Nucl Med. 2017. PMID: 28450569. doi:10.2967/jnumed.117.192658

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。